Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Real-World Treatment Patterns in Patients with Light Chain (AL) Amyloidosis: Analysis of the Optum US Electronic Health Records and Commercial Claims Database

Angela Dispenzieri, MD, Jeff Zonder, MD, James Hoffman, MD, Sandy W. Wong, MD, Michaela Liedtke, MD, Rafat Abonour, MD, Anita D'Souza, MBBS, Charlene Lee, MSc, Sandhya Nair, PhD MSc, Ravi Potluri, PGDM, Brendan M. Weiss, MD, Jessica Vermeulen, MD PhD, Annette Lam, MSc, Maneesha Mehra, MPH

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-140405

Published: 2020

Journal Articles

The Hematologist's Role in Amyloidosis Management: Disease Awareness, Diagnostic Workup, and Practice Patterns

Anita D'Souza, MBBS, Keren Osman, MD, Cristiana Costa Chase, DO, Azah Borham, PharmD, Marianna Bruno, PharmD

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-137740

Published: 2020

Journal Articles

TNB383B.0001: A Multicenter, Phase 1, Open-Label, Dose-Escalation Andexpansion Study of TNB-383B, a Bispecific Antibodytargeting BCMA in Subjects with Relapsed or Refractorymultiple Myeloma

Ben Buelow, MD PhD, Anita D'Souza, MBBS, Cesar Rodriguez, MD, Ravi Vij, MBBS, Rajneesh Nath, MD, Melinda Snyder, MS, Duy Pham, MBA, Ashwin Patel, PhD, Suhasini Iyer, PhD

Blood (2019) 134 (Supplement_1): 1874.

https://doi.org/10.1182/blood-2019-123220

Published: 2019

Journal Articles

Health Care Reimbursement and Service Utilization Among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings

Neil Dunavin, MD, Lih-Wen Mau, PhD MPH, Christa Lea Meyer, MS, Clint Divine, Al-Ola Abdallah, MD, Susan Leppke, MPH, Anita D'Souza, MBBS, Ellen Denzen, MS, Wael Saber, MD MS, Linda J. Burns, MD, Siddhartha Ganguly, MD

Blood (2018) 132 (Supplement 1): 832.

https://doi.org/10.1182/blood-2018-99-118423

Published: 2018

Journal Articles

Association between Transplant Volumes and 30-Day Readmissions Following Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in the US

Binod Dhakal, MBBS, Smith Giri, MBBS, Adam Levin, MD, Rein Lisa, Timothy S. Fenske, MD, Saurabh Chhabra, MD, Nirav N Shah, MD, Aniko Szabo, PhD, Anita D'Souza, MBBS, Marcelo C. Pasquini, MD, Parameswaran Hari, MBBS, MD, Mehdi Hamadani, MD

Blood (2018) 132 (Supplement 1): 617.

https://doi.org/10.1182/blood-2018-99-116196

Published: 2018

Journal Articles

Incidence and Predictors of 30-Day Readmissions Following Autologous Hematopoietic Cell Transplantation (auto-HCT) in the US

Blood (2018) 132 (Supplement 1): 3544.

https://doi.org/10.1182/blood-2018-99-118873

Published: 2018

Journal Articles

Phase I/II Trial of Bendamustine, Ixazomib and Dexamethasone (BID) in Patients (pts.) with Relapsed/Refractory Multiple Myeloma (RRMM)

Binod Dhakal, MBBS, Anita D'Souza, MBBS, Mehdi Hamadani, MD, Carlos E. Arce-Lara, MD, Katrina Schroeder, Saurabh Chhabra, MD, Nirav N Shah, MD, Katelyn Gauger, Taylor Keaton, Marcelo C. Pasquini, MD, Parameswaran Hari, MBBS, MD

Blood (2018) 132 (Supplement 1): 1998.

https://doi.org/10.1182/blood-2018-99-110832

Published: 2018

Journal Articles

Adjuvant Doxycycline to Enhance Anti-Amyloid Effects: Results from the DUAL (Doxycycline to Upgrade response in AL amyloidosis) Study

Anita D'Souza, MBBS, Kathryn E Flynn, PhD, Binod Dhakal, MBBS, Saurabh Chhabra, MD, Marcelo C Pasquini, MDMS, Parameswaran Hari, MBBS, MD

Blood (2018) 132 (Supplement 1): 1999.

https://doi.org/10.1182/blood-2018-99-114783

Published: 2018

Journal Articles

Incremental Financial and Health-Related Burden of Novel Drugs Used in the Treatment of Relapsed and/or Refractory Multiple Myeloma (RRMM): A Meta-Analysis of Phase III Randomized Controlled Trials (RCTs)

Binod Dhakal, MBBS, Ravi Narra, MD, Timothy Smunt, MBA, Angela Canadeo, Pharm D, Saurabh Chhabra, MD, Anita d'Souza, MBBS, MD, Bishal Gyawali, MD PhD, Parameswaran Hari, MD MRCP, MS, Saroj Niraula, MD

Blood (2017) 130 (Supplement 1): 3403.

https://doi.org/10.1182/blood.V130.Suppl_1.3403.3403

Published: 2017

Journal Articles

Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults

Anita D'Souza, MBBS, Heather R. Millard, MPH, Jennifer Knight, MD, Ruta Brazauskas, PhD, Jenny Vogel, Deborah Mattila, Kathryn Flynn, PhD, Stephanie J Lee, MD MPH, Mary M. Horowitz, MD MS, J. Douglas Rizzo, MD, Bronwen E. Shaw, PhD MRCP, FRCPath

Blood (2017) 130 (Supplement 1): 3447.

https://doi.org/10.1182/blood.V130.Suppl_1.3447.3447

Published: 2017

Journal Articles

Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients

Attaphol Pawarode, MD, Anita D'Souza, MBBS, Marcelo C. Pasquini, MD, Bryon Johnson, PhD, Thomas Braun, PhD, Binod Dhakal, MBBS, Mehdi Hamadani, MD, John M. Magenau, MD, Nirav N Shah, MD, Mary Mansour Riwes, DO, Brian Parkin, MD, Pavan Reddy, MD, Parameswaran Hari, MD MRCP, MS

Blood (2017) 130 (Supplement 1): 339.

https://doi.org/10.1182/blood.V130.Suppl_1.339.339

Published: 2017

Journal Articles

Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study

Saurabh Chhabra, MD, Parameswaran Hari, MD MRCP, MS, Alexis Visotcky, Nirav N Shah, MD, J. Douglas Rizzo, MD, Wael Saber, MD MS, Anita D'Souza, MBBS, Binod Dhakal, MBBS, Ashish Anshu, MS, PhD, Robert Thompson, Timothy S. Fenske, MD, Bronwen E. Shaw, PhD MRCP, FRCPath, William R. Drobyski, MD, Marcelo C. Pasquini, MD, Mehdi Hamadani, MD

Blood (2017) 130 (Supplement 1): 1974.

https://doi.org/10.1182/blood.V130.Suppl_1.1974.1974

Published: 2017

Journal Articles

Revised-International Staging System (R-ISS) Is Independently Predictive and Prognostic for Early Relapse (<24 months) after Upfront Autologous Hematopoietic Cell Transplantation (AHCT) for Newly Diagnosed Multiple Myeloma (MM

Sathish Kumar, Anita D'Souza, MBBS, Emma C. Scott, MD, Raphael Fraser, Omar Davila, Cristina J. Gasparetto, MD, Shaji K Kumar, MD, Tomer M Mark, MDMSc, Yago Nieto, MD PhD, Parameswaran Hari, MD MRCP, MS

Blood (2017) 130 (Supplement 1): 2024.

https://doi.org/10.1182/blood.V130.Suppl_1.2024.2024

Published: 2017

Journal Articles

Acquired Factor X Deficiency in Light Chain (AL) Amyloidosis Is Rare and Associated with Advanced Disease

Gina Patel, Parameswaran Hari, MD MRCP, MS, Aniko Szabo, PhD, Rein Lisa, Lisa M. Baumann Kreuziger, MD MS, Saurabh Chhabra, MD, Binod Dhakal, MBBS, Anita D'Souza, MBBS

Blood (2017) 130 (Supplement 1): 2363.

https://doi.org/10.1182/blood.V130.Suppl_1.2363.2363

Published: 2017

Journal Articles

Using "Big-Data" to Evaluate in-Hospital Morbidity and Mortality in Systemic Light Chain (AL) Amyloidosis after High Dose Therapy and Autologous Stem Cell Transplant (HDT/ASCT)

Binod Dhakal, MBBS, Xinran Qi, Guru Subramanian Guru Murthy, MBBS, Ravi Narra, MD, Aniko Szabo, PhD, Saurabh Chhabra, MD, Anita D'Souza, MBBS, Parameswaran Hari, MD MRCP, MS

Blood (2017) 130 (Supplement 1): 2170.

https://doi.org/10.1182/blood.V130.Suppl_1.2170.2170

Published: 2017

Journal Articles

A Comparison between 3 Staging Systems in Multiple Myeloma Using the Center for International Blood and Marrow Transplant Research (CIBMTR) Database

Emma Scott, Parameswaran Hari, MD MRCP, MS, Sathish Kumar, Raphael Fraser, Omar Davila, Yago Nieto, MD PhD, Tomer M Mark, MDMSc, Shaji K Kumar, MD, Cristina J. Gasparetto, MD, Anita D'Souza, MBBS

Blood (2017) 130 (Supplement 1): 3042.

https://doi.org/10.1182/blood.V130.Suppl_1.3042.3042

Published: 2017

Journal Articles

Significant Differences in Stem Cell Transplant Utilization Rates (STUR) of Autologous Hematopoietic Cell Transplant (AHCT) in Multiple Myeloma (MM) Based on Ethnicity without Differences in Efficacy. a CIBMTR Report

Jeffrey R. Schriber, MD, Parmeswaran Hari, MD MRCP, MS, Kwang Woo Ahn, PhD, Mingwei Fei, MS, Amrita Krishnan, MD, Anita D'Souza, MBBS, MD

Blood (2016) 128 (22): 1190.

https://doi.org/10.1182/blood.V128.22.1190.1190

Published: 2016

Journal Articles

Autologous Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: IMPACT of Age

Binod Dhakal, MDMS, Ariel Nelson, MD, Guru Subramanian Guru Murthy, MD, Raphael Fraser, PhD, Daniel Eastwood, Mehdi Hamadani, MD, Anita D'Souza, MBBS, MD, Parameswaran Hari, MD MRCP, MS

Blood (2016) 128 (22): 3456.

https://doi.org/10.1182/blood.V128.22.3456.3456

Published: 2016

Journal Articles

Phase I Study of Combination Chemotherapy Plus Ixazomib in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma (ALL)

Ehab Atallah, MD, Laura C Michaelis, MD, Karen B. Carlson, MD PhD, Anita D'Souza, MBBS, MD, Timothy S. Fenske, MD, Marcelo C. Pasquini, MD, Mehdi Hamadani, MD, Arielle Baim, Jessica Guhl, Hari Parameswaran, MD

Blood (2016) 128 (22): 5192.

https://doi.org/10.1182/blood.V128.22.5192.5192

Published: 2016

Journal Articles

Impact of Obesity on Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies

Ensi Voshtina, DO, Aniko Szabo, PhD, Mehdi Hamadani, MD, Tim S. Fenske, MD, Anita D'Souza, MBBS, MD, Wael Saber, MD MS, William R. Drobyski, MD, Parameswaran Hari, MBBS, MD MRCP, Nirav N. Shah, MD MSHP

Blood (2016) 128 (22): 4667.

https://doi.org/10.1182/blood.V128.22.4667.4667

Published: 2016

NARROW

Real-World Treatment Patterns in Patients with Light Chain (AL) Amyloidosis: Analysis of the Optum US Electronic Health Records and Commercial Claims Database

The Hematologist's Role in Amyloidosis Management: Disease Awareness, Diagnostic Workup, and Practice Patterns

TNB383B.0001: A Multicenter, Phase 1, Open-Label, Dose-Escalation Andexpansion Study of TNB-383B, a Bispecific Antibodytargeting BCMA in Subjects with Relapsed or Refractorymultiple Myeloma

Health Care Reimbursement and Service Utilization Among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings

Association between Transplant Volumes and 30-Day Readmissions Following Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in the US

Incidence and Predictors of 30-Day Readmissions Following Autologous Hematopoietic Cell Transplantation (auto-HCT) in the US

Phase I/II Trial of Bendamustine, Ixazomib and Dexamethasone (BID) in Patients (pts.) with Relapsed/Refractory Multiple Myeloma (RRMM)

Adjuvant Doxycycline to Enhance Anti-Amyloid Effects: Results from the DUAL (Doxycycline to Upgrade response in AL amyloidosis) Study

Incremental Financial and Health-Related Burden of Novel Drugs Used in the Treatment of Relapsed and/or Refractory Multiple Myeloma (RRMM): A Meta-Analysis of Phase III Randomized Controlled Trials (RCTs)

Patient-Reported Sleep Quality at Baseline Correlates with 1-Year Survival after Allogeneic Hematopoietic Cell Transplantation in Adults

Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients

Ixazomib for Chronic Graft-Versus-Host Disease (cGVHD) Prophylaxis in Patients Undergoing Allogeneic Transplantation (alloHCT): Preliminary Results of a Phase I/II Study

Revised-International Staging System (R-ISS) Is Independently Predictive and Prognostic for Early Relapse (<24 months) after Upfront Autologous Hematopoietic Cell Transplantation (AHCT) for Newly Diagnosed Multiple Myeloma (MM

Acquired Factor X Deficiency in Light Chain (AL) Amyloidosis Is Rare and Associated with Advanced Disease

Using "Big-Data" to Evaluate in-Hospital Morbidity and Mortality in Systemic Light Chain (AL) Amyloidosis after High Dose Therapy and Autologous Stem Cell Transplant (HDT/ASCT)

A Comparison between 3 Staging Systems in Multiple Myeloma Using the Center for International Blood and Marrow Transplant Research (CIBMTR) Database

Significant Differences in Stem Cell Transplant Utilization Rates (STUR) of Autologous Hematopoietic Cell Transplant (AHCT) in Multiple Myeloma (MM) Based on Ethnicity without Differences in Efficacy. a CIBMTR Report

Autologous Hematopoietic Cell Transplantation in Patients with Multiple Myeloma: IMPACT of Age

Phase I Study of Combination Chemotherapy Plus Ixazomib in Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma (ALL)

Impact of Obesity on Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only